Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019

The biotech universe exploded with "megadeals" in the first half of 2019 as Bristol-Myers Squibb (BMY) and AbbVie (ABBV) both announced takeovers worth a combined $137 billion, and the drug merger trend isn't expected to lose momentum going into the rest of the year.